Cancer Treatment

12. Cancer Treatment

It is a well-known paradox that many of the chemical agents currently used in the treatment of cancer are themselves carcinogenic. Virtually all the commonly-used alkylating agents, including the nitrogen mustards, HN2 and HN3, treatamine (TFM), chlorambucil, sacrolysin and melphalan, and busulphan (byleran) can induce cancer fairly readily in experimental animals.

Studies have proven conclusively that untreated cancer sufferers actually live up to four times longer than treated individuals.

For a type of cancer, people who refuse treatment lived for an average of 12 1/2 years. Those who accepted surgery and other kinds of treatment lived an average of only three years! Beyond a shadow of doubt, radical surgery on cancer patients does more harm than good.

According to Ivan Illich (Medical Nemesis), “There is little evidence of effective treatment of most cancers. The five-year survival rate in breast-cancer cases is 50 percent, regardless of the frequency of medical check-ups and regardless of the treatment used. Nor is there evidence that the rate differs from that among untreated women. Although practicing doctors and the publicists of the medical establishment stress the importance of early detection and treatment of this and several other types of cancer, epidemiologists have begun to doubt that early intervention can alter the rate of survival.”